CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?

Authors :: Muus, P.
Witte, T.J. de
Muus, P.
Witte, T.J. de
Source :: Lancet Haematology; e481; e482; 2352-3026; 7; 10; ~Lancet Haematology~e481~e482~~~2352-3026~7~10~~
Publication Year :: 2023
Abstract: 01 juli 2023<br />Item does not contain fulltext

Database :: OAIster
Journal :: Lancet Haematology; e481; e482; 2352-3026; 7; 10; ~Lancet Haematology~e481~e482~~~2352-3026~7~10~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1390436836
Document Type :: Electronic Resource

Tools